ActiGraph has announced its partnership with VivoSense to enhance secure access to regulated sensor data from patients in pharmaceutical clinical trials.

The strategic collaboration will enable both the companies to deliver support sponsor access to secure, regulated, analysed, and contextualised sensor data from patients in clinical trials.

VivoSense is a regulatory compliant, cloud based platform used for analysing and monitoring wearable sensor data for clinical research. VivoSense, with VivoCapture, provides pharmaceutical sponsors with secure access to contextualised sensor data, metadata, and raw signals.

This platform utilizes Azure authentication and authorization, computing, and storage in a regulated sensor data warehouse.

ActiGraph’s advanced wearable activity monitoring sensors provide high levels of continuous, high-resolution physiologic data to pharmaceutical companies.

The gathered analysis of these biometric data streams play a major role in today’s clinical research and helps to increase patient enrollment inclinical trials.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

VivoSense is capable of analysing data from any biometric sensor or combination of sensors to integrate, analyse, and derive new biomarkers which withstand regulatory scrutiny.

The large physiological data-sets generated by the wearable physiological sensors are important in monitoring health and understanding the effects of new medicines and other therapies in development.

VivoSense CEO and co-founder Tabakin said: “Providing context to collected wearable sensor data empowers our clients to make better sense of the data and investigate novel disease endpoints.

“Combining ActiGraph’s world-leading activity and sleep monitoring with other physiological measures, cleaned and analyzed by VivoSense, will provide important context to all clinical trials measures.”

Based in the US, ActiGraph is a provider of medical-grade physical activity and sleep monitoring solutions for the scientific communities, while VivoSense, also based in the US, is provides wearable sensor solutions for clinical research